FDA Adverse Event
Injury
Summary report: N
GORE EXCLUDER AAA ENDOPROSTHESIS
MDR report key: 3092344
·
Received April 29, 2013
Report
- Report Number
- 2017233-2013-00266
- Event Type
- Injury
- Date Received
- April 29, 2013
- Date of Event
- April 17, 2013
- Report Date
- April 17, 2013
- Manufacturer
- W.L. GORE & ASSOCIATES,INC
- Product Code
- MIH
- PMA / PMN Number
- P020004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SD, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
THE REVIEW OF THE MFG PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS.
Description of Event or Problem · 1
ON (B)(6) 2012, THIS PT WAS IMPLANTED WITH TWO GORE EXCLUDER AAA ENDOPROSTHESES TO TREAT AN ABDOMINAL AORTIC ANEURYSM. ON AN UNK DATE, IMAGING SHOWED A PROXIMAL TAPE I ENDOLEAK, REPORTEDLY DUE TO PROXIMAL NECK ANGULATION (AMOUNT UNK) AND INADEQUATE NECK LENGTH (APPROX 1 CM) BELOW THE RENAL ARTERIES. IT WAS REPORTED IT IS UNK IF ANEURYSM ENLARGEMENT OCCURRED AS A RESULT OF THE ENDOLEAK. ON (B)(6) 2013 AN AORTIC EXTENDER COMPONENT WAS IMPLANTED TO TREAT THE PROXIMAL TYPE I ENDOLEAK. FINAL ANGIOGRAPHY SHOWED RESOLUTION OF THE ENDOLEAK, AND THE PT TOLERATED THE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 184714 | GORE EXCLUDER AAA ENDOPROSTHESIS | MIH/SYSTE, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | W.L. GORE & ASSOCIATES,INC | 10613913 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 78 YR | Hospitalization| R | COZAAR| CRESTOR| VITAMIN D| COREG| ASPIRIN| LANOXIN |